Business Investment Opportunities

Our company operates as a NABL accredited diagnostic lab and corporate healthcare service provider, strategically located in Bangalore and Hyderabad. - We cater to diverse medical diagnostics needs, offering services ranging from pre-employment fitness assessments to retail walk-in and home visit options, making us a pivotal player in the B2C, B2B, and B2B2C markets. - We hold robust partnerships with 14 third-party aggregators and insurance companies, ensuring a steady referral stream and customer trust. - With 23 dedicated employees, we have successfully served over 30 mid-sized to multinational corporate organizations and several government entities across South India. - Our extensive network and strategic alliances with four key corporate healthcare management organizations enhance our market reach and service delivery efficiency. - The business's high valuation is attributed to our strong brand presence, comprehensive service range, and an excellent leadership team driving forward our unique corporate healthcare solutions. - The company boasts significant physical asset value with two operational offices located in major cities, Bengaluru and Hyderabad. - We hold all necessary licenses and compliance certifications, ensuring smooth operational continuity and reliability within the diagnostics and healthcare services industry. - Despite past operational challenges impacting sales, the business is now poised for normal operations.

The business operates in the diagnostic labs industry, specifically offering laboratory and radiology services in Port Moresby. - Company currently has 5 employees and is looking to expand its services to other provinces, including the addition of dental services and the improvement of radiology services. - There is a partnership opportunity for investors to contribute to the expansion of the business and potentially benefit from the growth of the company's services. - Company receives referrals from both government hospitals and private hospitals, indicating a level of trust and recognition within the healthcare community. - We receive around 10 patients per day for consultation and tests. - Majority of the revenue comes from diagnostic lab testing. - As a relatively new business, there is potential for significant growth and market penetration, particularly in underserved areas or in the expansion of specialized services such as dental care. - Business has local licenses and registration certificates.

Business Highlights: - Founded 4 years ago, began with a COVID-19 experiment using 1,300 samples, achieving an impressive 99.77% accuracy compared to RT-PCR. - Intellectual property: Secured a patent grant, solidifying our innovative approach in AI-driven diagnostics. - Accelerator & industry recognition: Selected for The Roux Institute’s Future of Healthcare acceleration program, providing mentorship and strategic growth opportunities. - Non-dilutive & early investment traction: Gained momentum with multiple grants and secured a $50K pre-seed investment, fueling research and development. - E. coli study success: Conducted a preclinical study demonstrating 87% accuracy, further validating our RF-based pathogen detection technology. - Funding & resources: Currently leveraging USD 725K in total grants and credits, including K in USD 70 K grants received, USD 350K in Google Cloud credits, and an expected USD 305K SBIR grant from NSF. - Industry partnerships & market strategy: -- NorDx is set to be our first commercial client upon market entry. - Recognition & awards: -- Accepted into the Nvidia Inception Program for AI innovation. -- Runner-up in the AWS x Nvidia pitch competition in Austin, positioning business at the forefront of AI-powered diagnostics. - Market Launch & Revenue. - Fundraising progress: Raising USD 3M to commercialize, with USD 105K secured through SAFE notes and strong investor interest. - Business Model & Revenue Potential: Projected first-year revenue of USD 3M, with sales of 600 diagnostic units upon launch. Scalable B2B model targeting diagnostic labs, hospitals, and healthcare providers. - Potential for recurring revenue streams through AI-powered diagnostic subscriptions and consumables. - Regulatory & Clinical Traction for a Competitive Edge. Ongoing clinical validation and regulatory alignment with CLIA/CAP-accredited labs. RF-based diagnostics provide a faster, non-invasive alternative to traditional molecular testing. - With high asset valuation, driven by significant equipment costs, the company stands out in the diagnostics sector with its advanced technological infrastructure. - With a compact team of 6 skilled employees, the business emphasizes agility and innovation in its operations, facilitating quick progress in the fast-paced diagnostic technology sector.

Business Highlights: - Founded 4 years ago, began with a COVID-19 experiment using 1,300 samples, achieving an impressive 99.77% accuracy compared to RT-PCR. - Intellectual property: Secured a patent grant, solidifying our innovative approach in AI-driven diagnostics. - Accelerator & industry recognition: Selected for The Roux Institute’s Future of Healthcare acceleration program, providing mentorship and strategic growth opportunities. - Non-dilutive & early investment traction: Gained momentum with multiple grants and secured a $50K pre-seed investment, fueling research and development. - E. coli study success: Conducted a preclinical study demonstrating 87% accuracy, further validating our RF-based pathogen detection technology. - Funding & resources: Currently leveraging USD 725K in total grants and credits, including K in USD 70 K grants received, USD 350K in Google Cloud credits, and an expected USD 305K SBIR grant from NSF. - Industry partnerships & market strategy: -- NorDx is set to be our first commercial client upon market entry. - Recognition & awards: -- Accepted into the Nvidia Inception Program for AI innovation. -- Runner-up in the AWS x Nvidia pitch competition in Austin, positioning business at the forefront of AI-powered diagnostics. - Market Launch & Revenue. - Fundraising progress: Raising USD 3M to commercialize, with USD 105K secured through SAFE notes and strong investor interest. - Business Model & Revenue Potential: Projected first-year revenue of USD 3M, with sales of 600 diagnostic units upon launch. Scalable B2B model targeting diagnostic labs, hospitals, and healthcare providers. - Potential for recurring revenue streams through AI-powered diagnostic subscriptions and consumables. - Regulatory & Clinical Traction for a Competitive Edge. Ongoing clinical validation and regulatory alignment with CLIA/CAP-accredited labs. RF-based diagnostics provide a faster, non-invasive alternative to traditional molecular testing. - With high asset valuation, driven by significant equipment costs, the company stands out in the diagnostics sector with its advanced technological infrastructure. - With a compact team of 6 skilled employees, the business emphasizes agility and innovation in its operations, facilitating quick progress in the fast-paced diagnostic technology sector.

The hospital operates in two buildings, with one dedicated entirely to patients and the other serving as a diagnostic center. - Approximately 65-70 employees, comprising nurses and workers, are employed, alongside 12-15 doctors who work on a weekly rotation. - Despite experiencing losses for around five months at the end of the previous year, the business is now maintaining a profit margin of 10%-15%. - On average, the hospital receives about 50 patients per day.

We have more than 500 clients including the Indian Army, CRPF, DLF, HCL, Americare, Wockhardt, Patanjali. - Expect very high growth rate because of patented innovations. - President award, Global entrepreneur award by IBM. - Founder has 6 years industrial experience. - The quantum jump in sales is due to improvements in business demand & the payments. We believe we'll generate revenue at this rate or could even exceed our target. - Have installed equipment and set-up over 500 - 600 large labs and 2,000+ smaller labs. We retain ownership over the assets while operating on a profit sharing model where we receive 30 percent of the revenue generated by the labs while charging a franchise fee in the range of INR 2 lakh to INR 25 lakh depending on the size of the lab. The.

A one stop low cost laboratory based in Gujarat. - We have two units one in Vadodara and other one Rajpipla. - We have two permanent doctors specializing in pathology services with an experience of 22 years and 6 years respectively. - We get around 70-80 patients on a daily basis. - We participated in commonwealth 2016 and our clinic was selected as one of the best clinics in health care sector. - Promoter was awarded as Youngest entrepreneur in a Medical Expo help in Delhi.

We are a startup planning to manufacture blood sugar measuring machines. - The business has not yet started operations and have been involved in research and development for the past 5+ years. - We have always been dedicated to pushing the boundaries of innovation in healthcare. - Over the years, we have seen remarkable success in developing cutting-edge solutions that have improved patient care, streamlined operations, and driven efficiency across the industry. - Today, we stand on the cusp of a new. Breakthrough - a product that has the potential to revolutionize healthcare delivery. We are thrilled to introduce you to our latest innovation non-invasive blood glucose meters. - This revolutionary product is poised to address the critical challenges within the healthcare sector including no blood, no pain, no needle, no prick, no spread of infection, and no bio-contamination. - Our team of expert researchers, engineers, and healthcare professionals has worked tirelessly to develop the product, which is designed to make the life of a diabetic patient more comfortable with no pain and multiple tests at no cost. - We have tied up with IIT Hyderabad and have been incubated by CFHE. - We have finished the final testing stage and can launch the product within a year. - Manufacturing will be done on a contract basis. - Promoters have over 15 years of experience in the healthcare industry. - The business has a registration certificate and the other licenses are yet to be applied for.